Transcutaneous canine breast cancer detection in Tunisia: a pilot study.
Cancer
Cancer screening test
Diagnosis
Smell
Working dogs
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
09
02
2023
accepted:
01
11
2023
medline:
31
1
2024
pubmed:
31
1
2024
entrez:
30
1
2024
Statut:
epublish
Résumé
Breast cancer in Tunisia is often diagnosed at a late stage with long delay in time to consultation and to diagnosis.The aim of this study is to estimate the sensitivity and specificity of the transcutaneous breast cancer detection by canine olfactionin Tunisian women and to identify the potential confounding factors. This is a diagnostic case control study that took place from October 2021 to November 2022 in the Department of Medical Oncology at the University Hospital Farhat Hached of Sousse and in the security and training dog center located in Sousse (K9 Dog Center Security & Training). A two-year-old male Belgian Malinois was trained to detect breast cancer on skin secretion samples in compresses that had been worn overnight by women on their breast and then a double-blind testing was performed. There was no contact between women and the dog. From the mentioned responses of the dog, four parameters were calculated: sensitivity, specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV). Two hundred women were included in this trial: 100 breast cancer (BC) patients recruited from Farhat Hached University Hospital of Sousse and 100 healthy volunteers (HV).The calculated sensitivity was 84% (95% CI 78-89%) and the calculated specificity was 81% (95% CI 75-86%). The calculated predictive values were: PPV = 83,51% (95% CI 78,37-88,65%) and NPV = 81,55% (95% CI 76.17-86.93%). In the multivariate study, only four confounding factors of test's sensitivity were retained: age (OR = 1.210 [95% CI = 1.085-1.349]; p = 0.001), history of diabetes(OR = 0.017 [95% CI = 0.001-0.228]; p = 0.002), sampling at hospital (OR = 0.010 [95% CI = 0.003-0.464]; p = 0.010) and testing during chemotherapy courses (OR = 0.034 [95% CI = 0.003-0.404]; p = 0.007).For test's specificity, we retained the three following confounding factors: age (OR = 1,104 [95% CI = 1.021-1.195]; p = 0.014), history of benign mastopathy (OR = 0.243 [95% CI = 0.074-0.805]; p = 0.021)and history of arterial hypertension (OR = 0.194 [95% CI = 0.053-0.707]; p = 0.013). This is a pilot study that opens new avenues in developing a reliable cancer diagnostic tool that integrates the dog's olfactory ability to detect breast cancer using a transcutaneous sampling method. It could be a pre-test to select patients who are eligible to a screening mammogram, especially in low-income countries where there is no national mammography screening program. PACTR. PACTR202201864472288, registration date 11/01/2022.
Sections du résumé
BACKGROUND
BACKGROUND
Breast cancer in Tunisia is often diagnosed at a late stage with long delay in time to consultation and to diagnosis.The aim of this study is to estimate the sensitivity and specificity of the transcutaneous breast cancer detection by canine olfactionin Tunisian women and to identify the potential confounding factors.
METHODS
METHODS
This is a diagnostic case control study that took place from October 2021 to November 2022 in the Department of Medical Oncology at the University Hospital Farhat Hached of Sousse and in the security and training dog center located in Sousse (K9 Dog Center Security & Training). A two-year-old male Belgian Malinois was trained to detect breast cancer on skin secretion samples in compresses that had been worn overnight by women on their breast and then a double-blind testing was performed. There was no contact between women and the dog. From the mentioned responses of the dog, four parameters were calculated: sensitivity, specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV).
RESULTS
RESULTS
Two hundred women were included in this trial: 100 breast cancer (BC) patients recruited from Farhat Hached University Hospital of Sousse and 100 healthy volunteers (HV).The calculated sensitivity was 84% (95% CI 78-89%) and the calculated specificity was 81% (95% CI 75-86%). The calculated predictive values were: PPV = 83,51% (95% CI 78,37-88,65%) and NPV = 81,55% (95% CI 76.17-86.93%). In the multivariate study, only four confounding factors of test's sensitivity were retained: age (OR = 1.210 [95% CI = 1.085-1.349]; p = 0.001), history of diabetes(OR = 0.017 [95% CI = 0.001-0.228]; p = 0.002), sampling at hospital (OR = 0.010 [95% CI = 0.003-0.464]; p = 0.010) and testing during chemotherapy courses (OR = 0.034 [95% CI = 0.003-0.404]; p = 0.007).For test's specificity, we retained the three following confounding factors: age (OR = 1,104 [95% CI = 1.021-1.195]; p = 0.014), history of benign mastopathy (OR = 0.243 [95% CI = 0.074-0.805]; p = 0.021)and history of arterial hypertension (OR = 0.194 [95% CI = 0.053-0.707]; p = 0.013).
CONCLUSION
CONCLUSIONS
This is a pilot study that opens new avenues in developing a reliable cancer diagnostic tool that integrates the dog's olfactory ability to detect breast cancer using a transcutaneous sampling method. It could be a pre-test to select patients who are eligible to a screening mammogram, especially in low-income countries where there is no national mammography screening program. PACTR.
ORG IDENTIFIER
UNASSIGNED
PACTR202201864472288, registration date 11/01/2022.
Identifiants
pubmed: 38291377
doi: 10.1186/s12885-023-11599-3
pii: 10.1186/s12885-023-11599-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
151Informations de copyright
© 2024. The Author(s).
Références
Cancer (IARC) TIA for R on. Global Cancer Observatory. 2022. https://gco.iarc.fr/ . Accessed 7 Dec 2022.
Mahjoub N, Salem KB, Mokrani A, Mansouri H, Achour L, Chraiet N, et al. Profil épidémiologique et anatomopathologique du cancer du sein dans la région du Nord-Ouest de la Tunisie Epidemiological and anatomopathological profil of breast cancer in the region of North-West of Tunisia. Tunis Med. 2021;99:8.
Belaid I, Fatma LB, Ezzairi F, Hochlaf M, Chabchoub I, Gharbi O, et al. Trends and current challenges of breast cancer in Tunisia: a retrospective study of 1262 cases with survival analysis. Breast J. 2018;24:846–8.
doi: 10.1111/tbj.13062
pubmed: 29781116
Landolsi A, Gahbiche S, Chaafii R, Chabchoub I, Fatma LB, Hochlef M, et al. Causes du Retard diagnostic du cancer du sein chez la femme Tunisienne : Série de 160 patientes au centre Tunisien. Tunis Med. 2010;88:4.
Ben Fatma L, Belaid I, Said N, Gahbiche S, Hochlef M, Chabchoub I, et al. What could be the reasons of late diagnosis of breast cancer in Tunisia? Tunis Med. 2018;96:665–71.
pubmed: 30746659
Guest C, Harris R, Sfanos KS, Shrestha E, Partin AW, Trock B, et al. Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer. PLoS One. 2021;16:e0245530.
doi: 10.1371/journal.pone.0245530
pubmed: 33596212
pmcid: 7888653
Bauër P, Leemans M, Audureau E, Gilbert C, Armal C, Fromantin I. Remote medical scent detection of cancer and infectious diseases with dogs and rats: a systematic review. Integr Cancer Ther. 2022;21:15347354221140516.
doi: 10.1177/15347354221140516
pubmed: 36541180
pmcid: 9791295
Willis CM, Church SM, Guest CM, Cook WA, McCarthy N, Bransbury AJ, et al. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ. 2004;329:712.
doi: 10.1136/bmj.329.7468.712
pubmed: 15388612
pmcid: 518893
McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, Janecki T. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther. 2006;5:30–9.
doi: 10.1177/1534735405285096
pubmed: 16484712
Gordon RT, Schatz CB, Myers LJ, Kosty M, Gonczy C, Kroener J, et al. The use of canines in the detection of human cancers. J Altern Complement Med. 2008;14:61–7.
doi: 10.1089/acm.2006.6408
pubmed: 18199013
Cornu J-N, Girardet C, Cussenot O. Des chiens dressés pour une nouvelle méthode de dépistage des cancers ? Prog En Urol - FMC. 2010;20:F135–8.
doi: 10.1016/j.fpurol.2010.04.004
Piqueret B, Bourachot B, Leroy C, Devienne P, Mechta-Grigoriou F, d’Ettorre P, et al. Ants detect cancer cells through volatile organic compounds. iScience. 2022;25.
Kure S, Iida S, Yamada M, Takei H, Yamashita N, Sato Y, et al. Breast cancer detection from a urine sample by dog sniffing: a preliminary study for the development of a new screening device, and a literature review. Biology. 2021;10:517.
doi: 10.3390/biology10060517
pubmed: 34200793
pmcid: 8230505
Pirrone F, Albertini M. Olfactory detection of cancer by trained sniffer dogs: a systematic review of the literature. J Vet Behav. 2017;19:105–17.
doi: 10.1016/j.jveb.2017.03.004
Thuleau A, Gilbert C, Bauër P, Alran S, Fourchotte V, Guillot E, et al. A New Transcutaneous Method for Breast Cancer Detection with Dogs. Oncology. 2019;96:110–3.
doi: 10.1159/000492895
pubmed: 30278460
du Sert NP, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLOS Biol. 2020;18:e3000410.
doi: 10.1371/journal.pbio.3000410
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.
doi: 10.2307/2529310
pubmed: 843571
Willis CM, Britton LE, Harris R, Wallace J, Guest CM. Volatile organic compounds as biomarkers of bladder cancer: sensitivity and specificity using trained sniffer dogs. Cancer Biomark. 2011;8:145–53.
doi: 10.3233/CBM-2011-0208
Horvath G, Järverud G af K, Järverud S, Horváth I. Human ovarian carcinomas detected by specific odor. Integr Cancer Ther. 2008;7:76–80.
doi: 10.1177/1534735408319058
pubmed: 18505901
Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, et al. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J. 2012;39:669–76.
doi: 10.1183/09031936.00051711
pubmed: 21852337
Walczak M, Jezierski T, Górecka-Bruzda A, Sobczyńska M, Ensminger J. Impact of individual training parameters and manner of taking breath odor samples on the reliability of canines as cancer screeners. J Vet Behav. 2012;7:283–94.
doi: 10.1016/j.jveb.2012.01.001
Elliker KR, Sommerville BA, Broom DM, Neal DE, Armstrong S, Williams HC. Key considerations for the experimental training and evaluation of cancer odour detection dogs: lessons learnt from a double-blind, controlled trial of prostate cancer detection. BMC Urol. 2014;14:22.
doi: 10.1186/1471-2490-14-22
pubmed: 24575737
pmcid: 3945616
Amundsen T, Sundstrøm S, Buvik T, Gederaas OA, Haaverstad R. Can dogs smell lung cancer? First study using exhaled breath and urine screening in unselected patients with suspected lung cancer. Acta Oncol. 2014;53:307–15.
doi: 10.3109/0284186X.2013.819996
pubmed: 23957595
Taverna G, Tidu L, Grizzi F, Torri V, Mandressi A, Sardella P, et al. Olfactory system of highly trained dogs detects prostate cancer in urine samples. J Urol. 2015;193:1382–7.
doi: 10.1016/j.juro.2014.09.099
pubmed: 25264338
Buono MJ, McKENZIE BK, Kasch FW. Effects of Ageing and Physical Training on the Peripheral Sweat Production of the Human Eccrine Sweat Gland. Age Ageing. 1991;20:439–41.
doi: 10.1093/ageing/20.6.439
pubmed: 1776594
Goodman JI. Diabetic anhidrosis. Am J Med. 1966;41:831–5.
doi: 10.1016/0002-9343(66)90040-4
pubmed: 5922894
Adams D, Cauquil C, Lozeron P. Dysautonomies des neuropathies périphériques. Presse Médicale. 2012;41:1128–36.
doi: 10.1016/j.lpm.2012.05.030
pubmed: 23021660
Quintero-Atencio J, Vásquez-León H, Pino-Quintero LM. Association of sweat sodium with arterial-blood pressure. N Engl J Med. 1966;274:1224–8.
doi: 10.1056/NEJM196606022742202
pubmed: 5935420
Wang C, Sun B, Guo L, Wang X, Ke C, Liu S, et al. Volatile Organic Metabolites Identify Patients with Breast Cancer, Cyclomastopathy, and Mammary Gland Fibroma. Sci Rep. 2014;4:5383.
doi: 10.1038/srep05383
pubmed: 24947160
pmcid: 4064322
Kumar S, Huang J, Abbassi-Ghadi N, Mackenzie HA, Veselkov KA, Hoare JM, et al. Mass spectrometric analysis of exhaled breath for the identification of volatile organic compound biomarkers in esophageal and gastric adenocarcinoma. Ann Surg. 2015;262:981–90.
doi: 10.1097/SLA.0000000000001101
pubmed: 25575255
Tacher S, Quignon P, Rimbault M, Dreano S, Andre C, Galibert F. Olfactory receptor sequence polymorphism within and between breeds of dogs. J Hered. 2005;96:812–6.
doi: 10.1093/jhered/esi113
pubmed: 16251519